Free Trial

Novozymes A/S (NVZMY) Earnings Date, Estimates & Call Transcripts

Novozymes A/S logo
$62.32 -0.01 (-0.02%)
As of 03:59 PM Eastern

Novozymes A/S Earnings Summary

Novozymes A/S posted Q1 2026 earnings on May 5, 2026, reporting an EPS of $0.51, which missed the consensus estimate of $0.62 by $0.11. With a trailing EPS of $1.40 and a P/E Ratio of 44.51, Novozymes A/S's earnings are expected to grow 6.61% next year, from $2.42 to $2.58 per share.

Q1 2026 Earnings Resources

Latest Q1 2026
Earnings Date
May. 5Estimated
Consensus EPS
(May. 5)
$0.62
Actual EPS
(May. 5)
$0.51 Missed By -$0.11
Get Novozymes A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novozymes A/S and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NVZMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVZMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novozymes A/S Analyst EPS Estimates

Current Year EPS Consensus Estimate
$2.42 EPS
Next Year EPS Consensus Estimate
$2.58 EPS

Novozymes A/S Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026$0.62$0.51 -$0.11$0.50--
2/25/2026Q4 2025$0.7910$0.35 -$0.4410$0.30$1.22B$1.18B

Data powered by Fiscal.ai.

Novozymes A/S Earnings - Frequently Asked Questions

Novozymes A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 5th, 2026 based off last year's report dates. Learn more on NVZMY's earnings history.

In the previous quarter, Novozymes A/S (OTCMKTS:NVZMY) missed the analysts' consensus estimate of $0.62 by $0.11 with a reported earnings per share (EPS) of $0.51. Learn more on analysts' earnings estimate vs. NVZMY's actual earnings.

Novozymes A/S (OTCMKTS:NVZMY) has a recorded annual revenue of $4.70 billion.

Novozymes A/S (OTCMKTS:NVZMY) has a recorded net income of $660.28 million. NVZMY has generated $1.40 earnings per share over the last four quarters.

Novozymes A/S (OTCMKTS:NVZMY) has a trailing price-to-earnings ratio of 44.51 and a forward price-to-earnings ratio of 25.75. The price/earnings-to-growth ratio is 1.17.

Novozymes A/S's earnings are expected to grow from $2.42 per share to $2.58 per share in the next year, which is a 6.61% increase.


This page (OTCMKTS:NVZMY) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners